Abstract
Mycobacteria produce an effective permeability layer that consists of a mycolic acid–containing cell wall. This protection confers a natural resistance to many chemical agents and results in a low permeability toward both hydrophilic and lipophilic agents. The permeability of cells is classically measured using methods that generally need cell suspensions and are hazardous with pathogens (e.g., nutrient and antibiotic uptake). A major problem encountered with mycobacteria is their propensity to form aggregates; the addition of detergent to the cell suspension is not recommended as this disorganizes the cell envelope, rendering it more permeable to antibiotics. To circumvent this problem, growing cells are uniformly labeled with [3H]-uracil, allowing a quantification of the aliquots; then, the uptake of [14C]-labeled probes is followed during the first minutes. To avoid the generation of aerosols associated with the commonly used filtration methods, centrifugation through an oil mixture is the preferred alternative technique for use with Mycobacterium tuberculosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Daffé, M., and Draper, P. (1998) The envelope layers of mycobacteria with reference to their pathogenicity. Adv. Microbiol. Physiol. 39, 131–203.
Goren, M. B. and Brennan P. J. (1979) Mycobacterial lipids: chemistry and biological activities, in Tuberculosis (Youmans, G. P., ed.) W.B. Saunders, Philadelphia, pp 63–193.
Brennan, P., and Nikaido, H. (1995) The envelope of mycobacteria. Annu. Rev. Biochem. 64, 29–63.
Draper, P. (1998) The outer parts of the mycobacterial envelope as permeability barriers. Frontiers Biosci. 3:d1253–d1261.
Draper, P. and Daffé, M. (2005) The cell envelope of M. tuberculosis with special reference to the capsule and the outer permeability barrier, in Tuberculosis (Cole, S. T. et al., eds.) ASM Press, Washington, DC, pp 261–273.
Jarlier, V., Gutman L. and Nikaido, H. (1991) Interplay of cell wall barrier and beta-lactamase activity determines high resistance to beta-lactam antibiotics in Mycobacterium chelonae. Antimicrob. Agents Chemother. 35, 1937–1939.
Trias, J., Jarlier, V., Benz, R. (1992) Porins in the cell wall of Mycobacterium chelonae. Science 258, 1479–1481.
Niederweis M. (2003) Mycobacterial porins—new channel proteins in unique outer membranes. Mol. Microbiol. 49, 1167–1177.
Nikaido, H., Kim S. H., and Rosenberg E.Y. (1993) Physical organization of lipids in the cell wall of Mycobacterium chelonae. Mol. Microbiol. 8, 1025–1030.
Jarlier, V. and Nikaido, H. (1994) Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol. Lett. 123, 11–18.
Liu, J., Barry C. E. III, Besra, G. S., and Nikaido, H. (1996) Mycolic acid structure determines the fluidity of the mycobacterial cell wall. J. Biol. Chem. 271, 29545–29551.
Nikaido, H., (2001) Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin. Cell Dev. Biol. 12, 215–223.
Ortalo-Magné, A., Lemassu, A., Lanéelle, M.-A., Bardou, F., Silve, G., Gounon P., Marchal, G., and Daffé, M. (1996) Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species. J. Bacteriol. 178, 456–461.
Camacho, L. R., Constant, P., Raynaud, C., Lanéelle, M. A., Triccas, J., A., Gicquel, B., Daffé, M., and Guilhot, C. (2001) Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. J. Biol. Chem. 276, 19845–19854.
Jarlier, V. and Nikaido, H. (1990) Permeability barrier to hydrophilic solutes in Mycobacterium chelonei. J. Bacteriol. 172, 1418–1423.
Jackson, M., Raynaud, C., Lanéelle, M.-A., Guilhot, C., Laurent-Winter, C., Ensergueix, D., Gicquel, B., and Daffé, M. (1999) Inactivation of the antigen 85C gene profoundly affects and alters the permeability of the Mycobacterium tuberculosis cell envelope. Mol. Microbiol. 31, 1573–1587.
Liu, J., and Nikaido, H. (1999) A mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids accumulates meromycolates. Proc. Natl. Acad. Sci. U. S. A. 96, 4011–4016.
Wang, L., Slayden, R. A., Barry, C. E. III and Liu, J. (2000) Cell wall structure of a mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids. J. Biol. Chem. 10, 7224–7229.
Liu, J., Rosenberg, Y. and Nikaido, H. (1995) Fluidity of the lipid domain of cell wall from Mycobacterium chelonae. Proc. Natl. Acad. Sci. U. S. A. 92, 11254–11258.
Yuan, Y., Crane D. C., Musser, J. M., Sreevatsan, S. and Barry, C. E. III (1997) MMAS-1, the branch point between cis- and trans- cyclopropane-containing oxygenated mycolates in Mycobacterium tuberculosis. J. Biol. Chem. 272, 10041–10049.
Dubnau, E., Chan, J., Raynaud, C., Mohan, V. P., Lanéelle, M.A., Yu, K., Quémard, A., Smith, I., and Daffé, M. (2000) Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol. Microbiol. 36, 630–637.
Stephan, J., Mailaender, C., Etienne, G., Daffé, M. and Niederweis, M. (2004) Multidrug resistance of a porin deletion mutant of Mycobacterium smegmatis. Antimicrob. Agents Chemother. 48, 4163–4170.
Bardou, F., Raynaud, C., Ramos, C., Lanéelle, M.A., and Lanéelle, G. (1998) Mechanism of isoniazid uptake in Mycobacterium tuberculosis. Microbiology 144, 2539–2544.
Raynaud, C., Papavinasasundaram, K.G., Speight, R.A., Springer, B., Sander, P., Böttger, E.C., Colston, J.C. and Draper, P. (2002) The function of OmpATb, a pore- forming protein of Mycobacterium tuberculosis. Mol. Microbiol. 46, 191–201.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Lanéelle, MA., Daffé, M. (2009). Transport Assays and Permeability in Pathogenic Mycobacteria. In: Parish, T., Brown, A. (eds) Mycobacteria Protocols. Methods in Molecular Biology, vol 465. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59745-207-6_9
Download citation
DOI: https://doi.org/10.1007/978-1-59745-207-6_9
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-58829-889-8
Online ISBN: 978-1-59745-207-6
eBook Packages: Springer Protocols